RA Capital Management - AQUINOX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of AQUINOX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$19,643,000
-45.7%
1,396,071
-36.1%
2.25%
-49.2%
Q1 2017$36,190,0000.0%2,184,047
-0.4%
4.44%
-13.4%
Q4 2016$36,190,000
+23.6%
2,191,9770.0%5.13%
+69.7%
Q3 2016$29,285,000
+161.4%
2,191,977
+29.6%
3.02%
+94.8%
Q2 2016$11,201,000
-24.9%
1,691,9770.0%1.55%
-18.7%
Q1 2016$14,923,000
-26.2%
1,691,977
+4.4%
1.91%
-4.7%
Q4 2015$20,217,000
-6.2%
1,619,977
+5.7%
2.00%
-35.4%
Q3 2015$21,557,0001,532,1513.10%
Other shareholders
AQUINOX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 400,900$1,062,0000.78%
EMORY UNIVERSITY 209,207$554,0000.37%
EcoR1 Capital, LLC 1,150,000$3,048,0000.29%
Baker Brothers Advisors 10,934,154$28,976,0000.22%
DLD Asset Management, LP 763,100$2,030,0000.15%
UNIVERSITY OF NOTRE DAME DU LAC 214,759$569,0000.11%
Kalos Management, Inc. 15,850$226,0000.10%
SPHERA FUNDS MANAGEMENT LTD. 257,613$683,0000.09%
DLD Asset Management, LP 379,900$1,007,0000.08%
DLD Asset Management, LP 379,300$1,009,0000.08%
View complete list of AQUINOX PHARMACEUTICALS INC shareholders